(RAPT) RAPT Therapeutics - Performance -83.8% in 12m
Compare RAPT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-89.02%
#162 in Group
Rel. Strength
1.66%
#7825 in Universe
Total Return 12m
-83.83%
#189 in Group
Total Return 5y
-95.19%
#129 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -78.75%
49th Percentile in Group
12m Total Return: RAPT (-83.8%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: RAPT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RAPT
| Total Return (including Dividends) | RAPT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -15.24% | 2.02% | 2.87% |
| 3 Months | -34.48% | -15.44% | -6.42% |
| 12 Months | -83.83% | -14.02% | 9.87% |
| 5 Years | -95.19% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | RAPT | XBI | S&P 500 |
| 1 Month | -2.40% | 57% | 89.4% |
| 3 Months | -70.6% | -82.3% | -72% |
| 12 Months | -91.0% | -53.1% | 49.3% |
| 5 Years | -71.8% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #185 | -16.9% | -17.6% |
| 3 Month | #95 | -22.5% | -30.0% |
| 12 Month | #188 | -81.2% | -85.3% |
| 5 Years | #136 | -93.5% | -97.7% |
FAQs
Does RAPT RAPT Therapeutics outperforms the market?
No,
over the last 12 months RAPT made -83.83%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months RAPT made -34.48%, while XBI made -15.44%.
Over the last 3 months RAPT made -34.48%, while XBI made -15.44%.
Performance Comparison RAPT vs Indeces and Sectors
RAPT vs. Indices RAPT is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -21.7% | -18.1% | -51.8% | -93.7% |
| US NASDAQ 100 | QQQ | -21.9% | -20.0% | -52.2% | -95.2% |
| US Dow Jones Industrial 30 | DIA | -21.9% | -16.9% | -50.8% | -90.2% |
| German DAX 40 | DAX | -23.8% | -34.5% | -77.4% | -109% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -22.3% | -21.5% | -51.0% | -89.5% |
| Hongkong Hang Seng | HSI | -25.2% | -31.5% | -61.3% | -95.9% |
| India NIFTY 50 | INDA | -19.3% | -17.5% | -53.7% | -86.2% |
| Brasil Bovespa | EWZ | -23.7% | -26.8% | -61.0% | -77.4% |
RAPT vs. Sectors RAPT is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -21.8% | -18.9% | -58.0% | -104% |
| Consumer Discretionary | XLY | -22.6% | -18.8% | -49.6% | -97.9% |
| Consumer Staples | XLP | -21.3% | -17.3% | -58.7% | -91.4% |
| Energy | XLE | -22.6% | -15.3% | -45.8% | -74.1% |
| Financial | XLF | -22.3% | -20.8% | -57.7% | -105% |
| Health Care | XLV | -17.9% | -10.9% | -46.6% | -77.9% |
| Industrial | XLI | -23.2% | -22.6% | -52.8% | -93.8% |
| Materials | XLB | -21.6% | -20.0% | -47.7% | -77.8% |
| Real Estate | XLRE | -21.3% | -21.4% | -54.2% | -97.3% |
| Technology | XLK | -22.5% | -22.0% | -49.5% | -90.8% |
| Utilities | XLU | -22.7% | -20.9% | -59.6% | -99.7% |
| Aerospace & Defense | XAR | -22.2% | -24.6% | -61.1% | -109% |
| Biotech | XBI | -13.6% | -17.3% | -30.7% | -69.8% |
| Homebuilder | XHB | -21.2% | -18.3% | -38.2% | -74.1% |
| Retail | XRT | -21.8% | -18.8% | -45.5% | -79.5% |